- Home
- CMA vs RGEN Comparison
CMA vs RGEN Comparison
Compare CMA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMA
- RGEN
- Stock Information
- Founded
- CMA 1849
- RGEN 1981
- Country
- CMA United States
- RGEN United States
- Employees
- CMA N/A
- RGEN N/A
- Industry
- CMA Major Banks
- RGEN Medical/Dental Instruments
- Sector
- CMA Finance
- RGEN Health Care
- Exchange
- CMA Nasdaq
- RGEN Nasdaq
- Market Cap
- CMA 7.1B
- RGEN 8.0B
- IPO Year
- CMA N/A
- RGEN N/A
- Fundamental
- Price
- CMA $58.57
- RGEN $131.55
- Analyst Decision
- CMA Hold
- RGEN Buy
- Analyst Count
- CMA 20
- RGEN 12
- Target Price
- CMA $62.95
- RGEN $172.67
- AVG Volume (30 Days)
- CMA 1.6M
- RGEN 847.4K
- Earning Date
- CMA 04-21-2025
- RGEN 04-29-2025
- Dividend Yield
- CMA 4.85%
- RGEN N/A
- EPS Growth
- CMA 4.95
- RGEN N/A
- EPS
- CMA 5.29
- RGEN N/A
- Revenue
- CMA $3,234,000,000.00
- RGEN $650,429,000.00
- Revenue This Year
- CMA $7.32
- RGEN $13.93
- Revenue Next Year
- CMA $3.12
- RGEN $14.35
- P/E Ratio
- CMA $11.04
- RGEN N/A
- Revenue Growth
- CMA N/A
- RGEN 4.88
- 52 Week Low
- CMA $45.32
- RGEN $102.97
- 52 Week High
- CMA $73.45
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- CMA 62.40
- RGEN 47.85
- Support Level
- CMA $54.42
- RGEN $123.10
- Resistance Level
- CMA $59.36
- RGEN $143.56
- Average True Range (ATR)
- CMA 1.21
- RGEN 6.82
- MACD
- CMA 0.73
- RGEN -0.65
- Stochastic Oscillator
- CMA 89.77
- RGEN 33.43
About CMA Comerica Incorporated
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.